Ekman A - Search Results

1

Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[[trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the formation of active metabolites in vivo.

Sonesson C, Boije M, Svensson K, Ekman A, Carlsson A, Romero AG, Martin IJ, Duncan JN, King LJ, Wikström H. Sonesson C, et al. Among authors: ekman a. J Med Chem. 1993 Oct 29;36(22):3409-16. doi: 10.1021/jm00074a022. J Med Chem. 1993. PMID: 8230131

2

Resolved 6,7,8,9-tetrahydro-N,N-dimethyl-3H-benz[e]indol-8-amine: central dopamine and serotonin receptor stimulating properties.

Wikström H, Andersson B, Svensson A, Humber LG, Asselin AA, Svensson K, Ekman A, Carlsson A, Nilsson I, Chidester C. Wikström H, et al. Among authors: ekman a. J Med Chem. 1989 Oct;32(10):2273-6. doi: 10.1021/jm00130a008. J Med Chem. 1989. PMID: 2571729

3

6,7,8,9-Tetrahydro-N,N-di-n-propyl-3H-benzindol-8-amines. Derivatives as potent and orally active serotonin 5-HT1A receptor agonists.

Stjernlöf P, Elebring T, Nilsson J, Andersson B, Lagerkvist S, Svensson K, Ekman A, Carlsson A, Wikström H. Stjernlöf P, et al. Among authors: ekman a. J Med Chem. 1994 Sep 30;37(20):3263-73. doi: 10.1021/jm00046a010. J Med Chem. 1994. PMID: 7932553

4

(S)- and (R)-8-(di-n-propylamino)-6,7,8,9-tetrahydro-3H-benz[e]indole-1- carbaldehyde: a new class of orally active 5-HT1A-receptor agonists.

Stjernlöf P, Gullme M, Elebring T, Andersson B, Wikström H, Lagerquist S, Svensson K, Ekman A, Carlsson A, Sundell S. Stjernlöf P, et al. Among authors: ekman a. J Med Chem. 1993 Jul 23;36(15):2059-65. doi: 10.1021/jm00067a002. J Med Chem. 1993. PMID: 8340910

5

6-Hydroxy-3-n-propyl-2,3,4,5-tetrahydro-1H-3-benzazepine and analogs: new centrally acting 5-HT1A receptor agonists.

Wikström H, Andersson B, Elebring T, Lagerkvist S, Hallnemo G, Pettersson I, Jovall PA, Svensson K, Ekman A, Carlsson A. Wikström H, et al. Among authors: ekman a. J Med Chem. 1992 Oct 30;35(22):3984-90. doi: 10.1021/jm00100a002. J Med Chem. 1992. PMID: 1433207

6

Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study.

Svensson K, Ekman A, Piercey MF, Hoffmann WE, Lum JT, Carlsson A. Svensson K, et al. Among authors: ekman a. Naunyn Schmiedebergs Arch Pharmacol. 1991 Sep;344(3):263-74. doi: 10.1007/BF00182999. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 1683686

7

The effects of 1-methyl-4-phenylpyridinium ion (MPP+) on the efflux and metabolism of endogenous dopamine in rat striatal slices.

Snape BM, Pileblad E, Ekman A, Magnusson T, Carlsson A, Engel J. Snape BM, et al. Among authors: ekman a. J Pharm Pharmacol. 1988 Sep;40(9):620-6. doi: 10.1111/j.2042-7158.1988.tb05321.x. J Pharm Pharmacol. 1988. PMID: 2907028

8

A high dose of EEDQ reduces pituitary dopamine D2 receptor density and the prolactin suppressive potency of agonists.

Ekman A, Eriksson E. Ekman A, et al. Eur J Pharmacol. 1993 Oct 26;243(3):295-9. doi: 10.1016/0014-2999(93)90189-o. Eur J Pharmacol. 1993. PMID: 7903944

9

Dopamine D3 receptor antisense influences dopamine synthesis in rat brain.

Nissbrandt H, Ekman A, Eriksson E, Heilig M. Nissbrandt H, et al. Among authors: ekman a. Neuroreport. 1995 Feb 15;6(3):573-6. doi: 10.1097/00001756-199502000-00041. Neuroreport. 1995. PMID: 7766866

10

Pituitary and brain D2 receptor density measured in vitro and in vivo in EEDQ treated male rats.

Ekman A, Eriksson E. Ekman A, et al. Life Sci. 1991;48(4):321-31. doi: 10.1016/0024-3205(91)90552-m. Life Sci. 1991. PMID: 1824955

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters